首页 >
法规速递
-
国家药监局关于发布仿制药参比制剂目录（第九十四批）及调出参比制剂目录品种清单（第二批）的通告（2025年第26号）-2025/7/15
2025-07-16查看详情 > -
国家药监局综合司关于印发2025年化妆品标准立项计划的通知-2025/8/21
2025-08-22查看详情 > -
Document: Minutes of the CAT meeting 12-14 August 2025 - written procedure-2025/9/30
2025-10-08查看详情 > -
Document: Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, (Multi trial) substantial modification, non-substantial modification, and Request for information (RFI)-2025/11/7
2025-11-10查看详情 > -
Document: Product Management Service (PMS) roadmap-2025/12/8
2025-12-09查看详情 > -
Page: European Shortages Monitoring Platform (ESMP)-2026/1/16
2026-01-19查看详情 > -
Document: Agenda - Medicine Shortages SPOC Working Party meeting 17 February 2026-2026/2/17
2026-02-27查看详情 > -
Page: Changing the (invented) name of a centrally authorised medicine: questions and answers-2026/3/25
2026-03-26查看详情 > -
Page: Liraglutide 6 mg/mL solution for injection in a prefilled pen product-specific bioequivalence guidance-2026/4/30
2026-05-02查看详情 > -
Comparability Protocols for Postapproval Changes to the Chemistry, Manufacturing, and Controls Information in an NDA, ANDA, or BLA (Final)-2022/10/13
2022-11-15查看详情 >
